Evidence map›Paper›PMID 31159413›Full record

ReviewViruses2019

Transcriptional Control and mRNA Capping by the GDP Polyribonucleotidyltransferase Domain of the Rabies Virus Large Protein.

Tomoaki Ogino, Todd J Green

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. mRNA Vaccine Platform: mRNA Production and Delivery.Russian journal of bioorganic chemistry · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Insight into the multifunctional RNA synthesis machine of rabies virus.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Structure of a rabies virus polymerase complex from electron cryo-microscopy.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Tomoaki OginoDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA. tomoaki.ogino@case.edu.
Todd J GreenDepartment of Microbiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. tgreen@uab.edu.
Cleveland Clinic Lerner College of Medicine · USUniversity of Alabama at Birmingham · US

Funding

Transcription and replication in nonsegmented negative-strand RNA virusesR01AI116738 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GREEN, TODD JASON · 2015 to 2019
$1.8M
mRNA synthesis and capping in nonsegmented negative strand RNA virusesR01AI093569 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI OGINO, TOMOAKI · 2012 to 2016
$1.8M
NIAID NIH HHS R01 AI093569NIAID NIH HHS R01 AI116738NIH HHS AI093569NIH HHS AI116738
6 · The paper itself

Abstract

Rabies virus (RABV) is a causative agent of a fatal neurological disease in humans and animals. The large (L) protein of RABV is a multifunctional RNA-dependent RNA polymerase, which is one of the most attractive targets for developing antiviral agents. A remarkable homology of the RABV L protein to a counterpart in vesicular stomatitis virus, a well-characterized rhabdovirus, suggests that it catalyzes mRNA processing reactions, such as 5'-capping, cap methylation, and 3'-polyadenylation, in addition to RNA synthesis. Recent breakthroughs in developing in vitro RNA synthesis and capping systems with a recombinant form of the RABV L protein have led to significant progress in our understanding of the molecular mechanisms of RABV RNA biogenesis. This review summarizes functions of RABV replication proteins in transcription and replication, and highlights new insights into roles of an unconventional mRNA capping enzyme, namely GDP polyribonucleotidyltransferase, domain of the RABV L protein in mRNA capping and transcription initiation.

Indexed as

DNA-Directed RNA PolymerasesRabies virusTranscription, GeneticViral ProteinsVirus ReplicationAnimalsGene Expression RegulationGenome, ViralHumansPolyribonucleotide NucleotidyltransferaseRhabdoviridaeRNA CapsRNA, ViralDNA-Directed RNA PolymerasesL protein, Rabies virusPolyribonucleotide NucleotidyltransferaseRNA CapsRNA, ViralViral Proteinsde novo initiationGDP polyribonucleotidyltransferaseL proteinmRNA cappingrabies virustranscription

Identifiers

PMID31159413
PMCPMC6631705
OpenAlexW2947637218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.